PREVENTION OF SUDDEN CARDIAC DEATH AFTER MYOCARDIAL INFARCTION BY DEFIBRILLATOR IMPLANTATION
Prevention of sudden cardiac death: from analysis of existing data to a large-scale clinical trial
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.
Latest news
OLOMOUC UNIVERSITY HOSPITAL – BEST RECRUITER IN THE PROFID EHRA TRIAL
The PROFID EHRA trial (NCT05665608) started in November 2023. It is the first randomised adequately powered assessment of the potential benefit of ICD therapy in myocardial infarction survivors with reduced LVEF under contemporary optimal medical therapy. Until now, almost 20 clinical sites in Austria, the Czech Republic, Germany and Spain have been opened for recruitment and …
Project Information
Grant agreement ID: 847999
DOI: 10.3030/847999
Start date: 1st January 2020
End date: 31st December 2024
Funded under: SOCIETAL CHALLENGES – Health, demographic change and well-being
Overall budget: € 23,307,508.08
Coordinated by: Charité – Universitätsmedizin Berlin